India’s ban on Covid-19 vaccine exports is likely to last until October, sources say, while pandemic disruption in India is hurting the global supply chain for many other medicines. During the country’s deadly second wave in March, the Indian government stopped vaccine exports and opted to inoculate the Indian population instead.
India is the largest manufacturer of Covid-19 vaccines globally, with Serum Institute of India (Maharashtra, India) expected—until now—to produce a third of this year’s global supply of AstraZeneca’s (Cambridge, UK) Vaxzevria vaccine.
The export ban was extended in May, and government sources have said that India is unlikely to resume major exports of Covid-19 vaccines until at least October as it diverts shots for domestic use. The Serum Institute said that it hoped to restart deliveries to the Covid-19 Vaccines Global Access (COVAX) initiative and to other countries by the end of this year.